Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sutent and Aromasin in HR+ Metastatic Breast Cancer
NCT00417885Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jun 2007
- Primary completion
- Jul 2009
- Countries
- 2
01
Overview
A Phase 2 trial of sunitinib in breast cancer, sponsored by Pfizer. Started Jun 2007; status: terminated.
02
Drugs
sunitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00417885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417885.